Q1 trading update: revenue is down 2.6% organically (volume -3.6%, price/mix +1%) and -5.5% on reported figures. By division, Europe recorded a +0.6% OG (improvement vs. Q4 but still weak), North America -7% OG (impacted by Cloverhill, excluding Cloverhill sales grew +1%) whereas the ROW recorded a good +7.8% (both price- and volume-driven). The FY guidance is maintained: management’s best current estimate is that FY18 EBITDA is expected to be broadly in line with FY17 EBITDA.
27 Nov 2017
Q1: no major surprises
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q1: no major surprises
Aryzta AG (0MFY:LON) | 0 0 1.6% | Mkt Cap: 2,195m
- Published:
27 Nov 2017 -
Author:
Anna Zyniewicz -
Pages:
2
Q1 trading update: revenue is down 2.6% organically (volume -3.6%, price/mix +1%) and -5.5% on reported figures. By division, Europe recorded a +0.6% OG (improvement vs. Q4 but still weak), North America -7% OG (impacted by Cloverhill, excluding Cloverhill sales grew +1%) whereas the ROW recorded a good +7.8% (both price- and volume-driven). The FY guidance is maintained: management’s best current estimate is that FY18 EBITDA is expected to be broadly in line with FY17 EBITDA.